STEMPOINT CAPITAL LP

Adviser information for STEMPOINT CAPITAL LP last updated from Form ADV on March 22nd, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 5
Investment Advisory/Research 3
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 1

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 4 $440.9M
Non-Discretionary 0 $0
Total 4 $440.9M

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 3 $166.6M
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses <5 $274.3M
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 0

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-127041
SEC ERA File Number 801-127041
SEC CIK Numbers 1952142
SEC CRD Numbers 324248
Legal Entity Identifier 549300SQHSDQCTFLCL20

Principal Office

520 MADISON AVE
19TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 7:00 AM - 5:00 PM EST
Tel: 212-540-4099, Fax: None

Chief Compliance Officer

SEAN CHUA TAN
CHIEF OPERATING OFFICER
520 MADISON AVE
19TH FLOOR
NEW YORK
NY
United States
Tel: 212-540-4099
(Full email address available in API data)

Regulatory Contact

MICHELLE ROSS
CHIEF INVESTMENT OFFICER
520 MADISON AVE
19TH FLOOR
NEW YORK
NY
United States
Tel: 212-540-4098
(Full email address available in API data)

Industry Affiliates

STEMPOINT CAPITAL MANAGEMENT GP LLC Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
STEMPOINT CAPITAL MASTER FUND LP Hedge Fund $64.8M $1.0M 22

Control Persons

Name Type Entity Title Since Ownership
STEMPOINT CAPITAL MANAGEMENT GP LLC Domestic Entity GP OF THE IM 09/2022 < 5%
TAN, SEAN, CHUA Individual CCO, COO AND MANAGING PARTNER 09/2022 25-50%
ROSS, MICHELLE Individual CIO & MANAGING PARTNER 09/2022 > 75%
ROSS, MICHELLE Individual STEMPOINT CAPITAL MANAGEMENT GP LLC CIO & MANAGING PARTNER 09/2022 > 75%
Gorynski, Robert Individual CFO 08/2023 < 5%

No. Employees, Historic

105020222023202420252 on 11/15/20222 on 11/18/20222 on 11/18/20224 on 2/2/20236 on 9/13/20235 on 3/22/2024

RAUM, Historic

500M250M0202320242025194100000 on 2/2/2023264000000 on 9/13/2023440900000 on 3/22/2024

No. Clients, Historic

105020222023202420250 on 11/15/20220 on 11/18/20220 on 11/18/20224 on 2/2/20234 on 9/13/20234 on 3/22/2024

Holdings

From latest 13F, filed August 13th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
AMICUS THERAPEUTICS INC COM 15M 1M
APPLIED THERAPEUTICS INC COM 10M 2M
ARCELLX INC COMMON STOCK 15M 281K
ARCUTIS BIOTHERAPEUTICS INC COM 350K 500K
ARCUTIS BIOTHERAPEUTICS INC COM 9M 965K
AUTOLUS THERAPEUTICS PLC SPON ADS 9M 3M
BIOHAVEN LTD COM 8M 233K
BLACK DIAMOND THERAPEUTICS I COM 3M 674K
CABALETTA BIO INC COM 9M 1M
CELLDEX THERAPEUTICS INC NEW COM NEW 5M 144K
CORBUS PHARMACEUTICALS HLDGS COM NEW 5M 101K
CRINETICS PHARMACEUTICALS IN COM 25M 551K
DENALI THERAPEUTICS INC COM 6M 251K
EDGEWISE THERAPEUTICS INC COM 5M 271K
FULCRUM THERAPEUTICS INC COM 4M 696K
GSK PLC SPONSORED ADR 9M 246K
HELIX ACQUISITION CORP II CL A ORD SHS 2M 200K
IDEAYA BIOSCIENCES INC COM 4M 102K
IMMATICS N.V SHS 6M 502K
IMMUNOCORE HLDGS PLC ADS 12M 339K
IMMUNOVANT INC COM 27M 1M
INSMED INC COM PAR $.01 6M 87K
JANUX THERAPEUTICS INC COM 4M 93K
JASPER THERAPEUTICS INC COM NEW 3M 144K
KALVISTA PHARMACEUTICALS INC COM 9M 737K
LARIMAR THERAPEUTICS INC COM 5M 704K
MERCK & CO INC COM 10M 82K
MERUS N V COM 17M 289K
NEUROGENE INC COM 3M 79K
NURIX THERAPEUTICS INC COM 4M 203K
PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS 2M 150K
PERSPECTIVE THERAPEUTICS INC COM NEW 3M 344K
PRAXIS PRECISION MEDICINES I COM NEW 1M 29K
PROTARA THERAPEUTICS INC COM STK 2M 984K
PYXIS ONCOLOGY INC COMMON STOCK 4M 1M
ROIVANT SCIENCES LTD SHS 29M 3M
SILENCE THERAPEUTICS PLC ADS 2M 125K
SPYRE THERAPEUTICS INC COM NEW 4M 150K
SURROZEN INC COM NEW 2M 144K
SYNDAX PHARMACEUTICALS INC COM 29M 1M
TSCAN THERAPEUTICS INC COM 5M 845K
VIGIL NEUROSCIENCE INC COM 3M 744K
VISTAGEN THERAPEUTICS INC COM 2M 617K
VISTAGEN THERAPEUTICS INC COM 4M 1M